- Tongwei’s Chairwoman discusses BC cell strategy in Q3 2023 briefing.
- Uncertainty if BC cells will dominate the market.
- BC cells valued for aesthetics, but lag in mass production and reliability.
- Tongwei commits to BC cell R&D and market monitoring.
- Future focus on adapting to market demand changes.
Insights of Back Contact cells from Tongwei
